IPO Timeline
Broker Results (T-2)
2022-02-16
Some brokers release in afternoon
Grey Market (T-1)
2022-02-17
Afternoon
HKEX Allotment (T-1)
2022-02-17
Evening
Registrar Allotment (T-1)
2022-02-17
Evening
Listing Day (T)
2022-02-18
First day of trading
Company Overview
| Stock Name | 清晰醫療集團控股有限公司 |
|---|---|
| Stock Code | 01406 |
| Company Full Name | 清晰醫療集團控股有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要在香港從事提供眼科服務。 |
| Listing Date | 2022-02-18 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港九龍旺角西洋菜南街2A號銀城廣場20樓 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://www.claritymedic.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 1.60 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 21,760,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 1.54 |
|---|---|
| First Day Open | HK$ 1.59 |
| First Day Change | -3.75% |
| First Day Volume | 42495000.0 |
| First Day Turnover | 66054800.0 |
Use of Proceeds
| Use of Proceeds | 1、約44.8%或79.4百萬港元將用作于香港成立兩家新醫療中心以提供眼科服務； 2、約30.5%或54.1百萬港元將用作收購大灣區內選定城市的一至兩家眼科診所、眼科門診部或眼科醫院的多數及╱或少數股權； 3、約14.7%或26.1百萬港元，將用于與合適的合作伙伴在中國設立醫療中心以提供眼科醫療服務； 4、約10.0%或17.7百萬港元將用作營運資金及其他一般企業用途。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
中国光大融资有限公司 CE ACE409
Overall Coordinators (3)
中国光大证券（香港）有限公司 CE AAW536
招银国际融资有限公司 CE AVM940
中泰国际证券有限公司 CE BAA855
Joint Bookrunners (11)
中国光大证券（香港）有限公司 CE AAW536
招银国际融资有限公司 CE AVM940
中泰国际证券有限公司 CE BAA855
农银国际证券有限公司 CE ACX411
交银国际证券有限公司 CE APJ121
Bradbury Securities Limited CE AAC913
民银证券有限公司 CE APU820
第一上海证券有限公司 CE ABV488
富途证券国际（香港）有限公司 CE AZT137
国泰君安证券（香港）有限公司 CE ABY236
申万宏源证券（香港）有限公司 CE AAC927
Joint Lead Managers (13)
中国光大证券（香港）有限公司 CE AAW536
招银国际融资有限公司 CE AVM940
中泰国际证券有限公司 CE BAA855
农银国际证券有限公司 CE ACX411
交银国际证券有限公司 CE APJ121
Bradbury Securities Limited CE AAC913
Chuenman Securities Limited CE BGP488
民银证券有限公司 CE APU820
第一上海证券有限公司 CE ABV488
富途证券国际（香港）有限公司 CE AZT137
国泰君安证券（香港）有限公司 CE ABY236
申万宏源证券（香港）有限公司 CE AAC927
华盛资本证券有限公司 CE AUL711
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | To be extracted |
|---|---|
| Company Secretary | 楊霈宜 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 3W Partners Fund I L.P.(32.52%);謝偉業(20.79%);無錫藥明康德新藥開發股份有限公司(15.33%) |
|---|
IPO Timeline
